Study of the Pharmacokinetics/Safety of Sorafenib + Capecitabine in Advanced Solid Tumors
This study has been completed.
Sponsor:
Sarah Cannon Research Institute
Collaborator:
Bayer
Information provided by (Responsible Party):
Sarah Cannon Research Institute
ClinicalTrials.gov Identifier:
NCT00613145
First received: January 17, 2008
Last updated: January 31, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | May 2010 |
| Primary Completion Date: | May 2009 (Final data collection date for primary outcome measure) |